DEYCX
Price
$14.09
Change
+$0.03 (+0.21%)
Updated
Dec 3 closing price
Net Assets
164.31M
GFACX
Price
$76.08
Change
+$0.45 (+0.60%)
Updated
Dec 3 closing price
Net Assets
338.91B
Interact to see
Advertisement

DEYCX vs GFACX

Header iconDEYCX vs GFACX Comparison
Open Charts DEYCX vs GFACXBanner chart's image
BNY Mellon Large Cap Equity C
Price$14.09
Change+$0.03 (+0.21%)
VolumeN/A
Net Assets164.31M
American Funds Growth Fund of Amer C
Price$76.08
Change+$0.45 (+0.60%)
VolumeN/A
Net Assets338.91B
DEYCX vs GFACX Comparison Chart in %
View a ticker or compare two or three
VS
DEYCX vs. GFACX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DEYCX is a StrongBuy and GFACX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 339B vs. DEYCX (164M). DEYCX (0.00) and GFACX (0.00) have matching dividends . DEYCX was incepted earlier than GFACX: DEYCX (17 years) vs GFACX (25 years). DEYCX (2.08) is less costly to investors than GFACX (1.36). DEYCX is a more actively managed with annual turnover of: 39.80 vs. GFACX (25.00). GFACX has a lower initial minimum investment than DEYCX: GFACX (250) vs DEYCX (1000). GFACX annual gain was more profitable for investors over the last year : 4.93 vs. DEYCX (-17.67). GFACX return over 5 years is better than : 23.08 vs. DEYCX (-41.60).
DEYCXGFACXDEYCX / GFACX
Total Expense Ratio1.751.36129%
Annual Report Gross Expense Ratio2.081.36153%
Fund Existence17 years25 years-
Gain YTD13.13518.11573%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets164M339B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year-17.674.93-358%
Returns for 3 years-29.0254.70-53%
Returns for 5 years-41.6023.08-180%
Returns for 10 years-17.4574.33-23%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CBBCX6.74N/A
N/A
AB Relative Value C
VNVCX22.41N/A
N/A
Natixis Vaughan Nelson Mid Cap C
BHSRX65.39N/A
N/A
BlackRock Health Sciences Opps R
AWIIX16.64N/A
N/A
CIBC Atlas Income Opportunities Instl
ESAGX13.63N/A
N/A
Ashmore Emerging Markets Equity ESG A